VEZIMED

This brand name is authorized in Cyprus, Malta, Romania

Active ingredients

The drug VEZIMED contains one active pharmaceutical ingredient (API):

1 Solifenacin
UNII KKA5DLD701 - SOLIFENACIN SUCCINATE

Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor.

Read about Solifenacin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VEZIMED Film-coated tablet Web Search MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G04BD08 Solifenacin G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics
Discover more medicines within G04BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: MT Medicines Authority Identifier(s): MA032/10201, MA032/10202
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W63708001, W63708002, W63708003, W63708004, W63708005, W63708006, W63708007, W63708008, W63708009, W63708010, W63708011, W63708012, W63708013, W63708014, W63709001, W63709002, W63709003, W63709004, W63709005, W63709006, W63709007, W63709008, W63709009, W63709010, W63709011, W63709012, W63709013, W63709014

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.